AEGFX
Price
$56.46
Change
+$0.48 (+0.86%)
Updated
Jan 30 closing price
Net Assets
130B
FDVAX
Price
$26.24
Change
+$0.31 (+1.20%)
Updated
Jan 30 closing price
Net Assets
1.34B
Ad is loading...

AEGFX vs FDVAX

Header iconAEGFX vs FDVAX Comparison
Open Charts AEGFX vs FDVAXBanner chart's image
American Funds Europacific Growth F1
Price$56.46
Change+$0.48 (+0.86%)
VolumeN/A
Net Assets130B
Fidelity Advisor Diversified Intl A
Price$26.24
Change+$0.31 (+1.20%)
VolumeN/A
Net Assets1.34B
AEGFX vs FDVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEGFX vs. FDVAX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEGFX is a Hold and FDVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
AEGFX has more cash in the bank: 130B vs. FDVAX (1.34B). AEGFX pays higher dividends than FDVAX: AEGFX (1.48) vs FDVAX (1.11). AEGFX was incepted earlier than FDVAX: AEGFX (24 years) vs FDVAX (26 years). AEGFX is a more actively managed with annual turnover of: 34.00 vs. FDVAX (23.00). FDVAX has a lower initial minimum investment than AEGFX: FDVAX (0) vs AEGFX (250). FDVAX annual gain was more profitable for investors over the last year : 5.84 vs. AEGFX (4.99). FDVAX return over 5 years is better than : 11.87 vs. AEGFX (9.51).
AEGFXFDVAXAEGFX / FDVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years26 years-
Gain YTD5.6124.556123%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets130B1.34B9,687%
Annual Yield % from dividends1.481.11133%
Returns for 1 year4.995.8485%
Returns for 3 years-2.83-1.45195%
Returns for 5 years9.5111.8780%
Returns for 10 years23.8138.5062%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRI196.192.39
+1.23%
Darden Restaurants
MC77.770.41
+0.53%
Moelis & Company
NGNE15.530.02
+0.13%
Neurogene
NXTC0.80N/A
-0.03%
NextCure
QCRH78.13-0.25
-0.32%
QCR Holdings